We are live on ! Find out more
LJPC

La Jolla Pharmaceutical

Delisted

LJPC was delisted on the 19th of August, 2022.

73 hedge funds and large institutions have $256M invested in La Jolla Pharmaceutical in 2016 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 30 increasing their positions, 17 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

191% more call options, than puts

Call options by funds: $3.57M | Put options by funds: $1.22M

76% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 17

43% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 7

4% more funds holding

Funds holding: 70 → 73 (+3)

0.99% less ownership

Funds ownership: 88.49% → 87.5% (-0.99%)

23% less capital inflows, than outflows

Capital inflows: $24.1M | Capital outflows: $31.1M

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
73
Holders Change
+3
Holders Change %
+4.29%
% of All Funds
1.94%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
10
Increased
30
Reduced
17
Closed
7
Calls
$3.57​M
Puts
$1.22​M
Net Calls
+$2.34​M
Net Calls Change
+$1.44​M

LJPC Hedge Fund Activity: Q2 2016 in Review

73 of the 3,756 institutional investors tracked by Wall St. Rank reported a position in La Jolla Pharmaceutical (LJPC) for Q2 2016, worth a combined $256M — down 24% from $337M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new LJPC positions and 7 closed out — a net gain of 3 holders — while 30 added to existing stakes and 17 trimmed.

The largest buyer was Perceptive Advisors, adding an estimated $11.4M. The largest seller was Visium Asset Management, exiting entirely with an estimated $24.8M sold.

  • 73 institutional investors held La Jolla Pharmaceutical (LJPC) as of Q2 2016, up from 70 in Q1 2016.
  • Funds reported $256M of La Jolla Pharmaceutical stock for Q2 2016, down 24% quarter-over-quarter.
  • 10 funds opened new La Jolla Pharmaceutical positions in Q2 2016 and 7 closed out, a net change of +3 holders.
  • The largest La Jolla Pharmaceutical buyer in Q2 2016 was Perceptive Advisors, an estimated $11.4M added.
  • The largest La Jolla Pharmaceutical seller in Q2 2016 was Visium Asset Management, an estimated $24.8M sold.

Based on aggregated 13F filings for Q2 2016.